Whitepaper
Optimal Preclinical Formulation Development
14 Jul 2022
en
Excipients play a vital role in drug release profiles, long-term stability, and the ultimate manufacturability of the drug product. We investigate critical interactions between the API and potential excipients to optimize your formulation early.
Broad-spectrum excipient compatibility studies to investigate critical API-excipient interactions.
Selection of the most appropriate excipients tailored for final dosage form design.
Compatibility studies for packaging materials, including extractable and leachable risk assessments.
Our selection process is specifically tailored to your API to directly improve bioavailability and exposure levels. We base every decision on four critical pillars:
Have a question or need support with your project? Please complete the form, and our team will get back to you shortly.
Our capabilities span three specialized platforms:
Small Molecule
Crystal Bio Solutions
Crystal NAX
By providing your e-mail address, you agree to receive an e-mail response from Crystal Pharmatech to your inquiry. The information you submit will be governed by our Privacy Policy.
Subscribe to be the first to get the updates!